Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

Authors

Institutions

Publication Details

Journal
Digestive and Liver Disease
Published
2025-11-22
DOI
https://doi.org/10.1016/j.dld.2025.11.003
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

Jérémie H. Lefèvre, Benoist Chibaudel, Rosine Guimbaud, Raphaël Colle et al.
1 citations
Digestive and Liver Disease
Cancer Immunotherapy and Biomarkers
1.05
article

Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES)

Jérémie H. Lefèvre, Benoist Chibaudel, Rosine Guimbaud, Raphaël Colle, David Tougeron, Angélique Vienot, Clémence Toullec, Denis Smith, Aurélien Dupré, Olivier Dubreuil, Romain Cohen, Dewi Vernerey, Marie‐Line Garcia Larnicol
article en
1 citations

Abstract

No abstract available for this paper.
Digestive and Liver DiseaseVol. 58(1)
Inserm (FR), Université de Poitiers (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Besançon (FR), Institute Mutualiste Montsouris (FR), Methodology and Quality of Life Unit in Oncology (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Saint-Antoine (FR), Centre Léon Bérard (FR), Groupe Hospitalier Diaconesses Croix Saint-Simon (FR), Hôpital Cardiologique du Haut-Lévêque (FR), Hôpital Rangueil (FR), GERCOR (France) (FR), Centre de Recherche Saint-Antoine (FR), Institut Hospitalier Franco Britannique (FR), Institut Sainte Catherine (FR)
Openalex Percentile: Top 16%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 – PRODIGE 84 phase II trial (PREMICES) — Jérémie H. Lefèvre, Benoist Chibaudel, et al. · Digestive and Liver Disease (2025) | TGRS Research Map | TGRS